AVNS icon

Avanos Medical

15.92 USD
-0.13
0.81%
At close Jan 17, 4:00 PM EST
After hours
15.92
+0.00
0.00%
1 day
-0.81%
5 days
5.43%
1 month
-6.46%
3 months
-32.57%
6 months
-29.68%
Year to date
0.57%
1 year
-15.41%
5 years
-51.96%
10 years
-64.99%
 

About: Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Employees: 3,771

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

21% more capital invested

Capital invested by funds: $852M [Q2] → $1.03B (+$176M) [Q3]

12% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 33

0% more funds holding

Funds holding: 257 [Q2] → 257 (+0) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

0.04% less ownership

Funds ownership: 93.16% [Q2] → 93.12% (-0.04%) [Q3]

9% less call options, than puts

Call options by funds: $149K | Put options by funds: $163K

17% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 75

Research analyst outlook

We haven’t received any recent analyst ratings for AVNS.

Financial journalist opinion

Neutral
PRNewsWire
2 weeks ago
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga. , Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43rd  Annual J.P.
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for December 11th
AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024.
New Strong Sell Stocks for December 11th
Neutral
PRNewsWire
2 months ago
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m.
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
Neutral
PRNewsWire
2 months ago
ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025
ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025.
ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025
Neutral
PRNewsWire
2 months ago
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues.
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
Neutral
PRNewsWire
2 months ago
Avanos Medical Launches New CORGRIP® SR
Advancement to reduce dislodgement in feeding tube retention systems ALPHARETTA, Ga. , Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio.
Avanos Medical Launches New CORGRIP® SR
Positive
Zacks Investment Research
2 months ago
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
Neutral
Zacks Investment Research
2 months ago
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate.
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
Neutral
Seeking Alpha
2 months ago
Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript
Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Chairman Michael Greiner - Senior VP, CFO & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Danny Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024.
Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Avanos Medical (AVNS) Q3 Earnings Meet Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago.
Avanos Medical (AVNS) Q3 Earnings Meet Estimates
Charts implemented using Lightweight Charts™